ALYREF and hepatocellular carcinoma: In sorafenib-resistant hepatocellular carcinoma (HCC), NSUN2 cooperates with ALYREF to maintain the stability and high expression of the long non-coding RNA MALAT1 via its m5C methyltransferase activity (45).